Camacho F

References (4)

Title : Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease - Smith_1997_J.Pharmacol.Exp.Ther_280_710
Author(s) : Smith CP , Bores GM , Petko W , Li M , Selk DE , Rush DK , Camacho F , Winslow JT , Fishkin R , Cunningham DM , Brooks KM , Roehr J , Hartman HB , Davis L , Vargas HM
Ref : Journal of Pharmacology & Experimental Therapeutics , 280 :710 , 1997
PubMedID: 9023283

Title : Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine - Bores_1996_J.Pharmacol.Exp.Ther_277_728
Author(s) : Bores GM , Huger FP , Petko W , Mutlib AE , Camacho F , Rush DK , Selk DE , Wolf V , Kosley RW, Jr. , Davis L , Vargas HM
Ref : Journal of Pharmacology & Experimental Therapeutics , 277 :728 , 1996
PubMedID: 8627552

Title : Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat - Camacho_1996_Psychopharmacology_124_347
Author(s) : Camacho F , Smith CP , Vargas HM , Winslow JT
Ref : Psychopharmacology , 124 :347 , 1996
PubMedID: 8739550

Title : Cholinergic modulation of a decrement in social investigation following repeated contacts between mice - Winslow_1995_Psychopharmacology.(Berl)_121_164
Author(s) : Winslow JT , Camacho F
Ref : Psychopharmacology (Berl) , 121 :164 , 1995
PubMedID: 8545521